Long-Term Improvements in Health-Related Quality of Life of Patients With Moderate to Severe Plaque Psoriasis Treated With Certolizumab Pegol: Results from the CIMPASI-1 and CIMPASI-2 Phase 3 Trials. J of Skin 2021, 5 (1), s20. https://doi.org/10.25251/skin.5.supp.20.